|1.||Rosen, Antony: 15 articles (01/2014 - 07/2002)|
|2.||Gershwin, M Eric: 15 articles (01/2013 - 05/2002)|
|3.||Wolchok, Jedd D: 11 articles (05/2014 - 10/2002)|
|4.||Houghton, Alan N: 10 articles (01/2013 - 10/2002)|
|5.||Herrmann, Martin: 9 articles (01/2015 - 03/2006)|
|6.||Shoenfeld, Yehuda: 8 articles (06/2015 - 05/2004)|
|7.||Cohen, Irun R: 8 articles (11/2014 - 01/2003)|
|8.||Kato, Tomohiro: 8 articles (02/2009 - 01/2004)|
|9.||Turk, Mary Jo: 8 articles (03/2008 - 10/2002)|
|10.||Venables, Patrick J: 7 articles (01/2015 - 01/2008)|
|1.||Autoimmune Diseases (Autoimmune Disease)
01/01/2015 - "Indeed, the selective delivery of autoantigens to liver sinusoidal endothelial cells could induce autoantigen-specific Tregs in vivo, providing effective treatment of autoimmune disease. "
03/01/2006 - "These findings have implications regarding the etiopathogenesis of autoimmune diseases such as SLE, in which impaired clearance of dead cells may foster autoimmunity by the release of potential autoantigens."
11/01/2012 - "Observations of defective clearance of dying cells in SLE combined with the generation and exposure of nuclear autoantigens during apoptosis have led to the hypothesis that improperly cleared apoptotic debris constitutes a source of autoantigens capable of triggering autoimmune disease. "
11/01/2005 - "The identification of disease related autoantigens targeted by pathogenic T- and B-cell responses is crucial for the development of improved therapies for autoimmune diseases. "
08/01/2003 - "Indeed, autoantigens are concentrated on the surface of apoptotic cells, and defective clearance of apoptotic bodies is associated with the occurrence of systemic autoimmune disease. "
05/01/2013 - "A major reason for this is that T cells specific for tumor self-antigens and neoantigens are eliminated or inactivated through mechanisms of tolerance. "
04/01/2012 - "In this work, we improved the performance of these bacterial vectors through several approaches in different murine cancer models involving non-self-antigens or self-antigens. "
04/01/2005 - "Improved approach to identify cancer-associated autoantigens."
08/01/2012 - "These studies provide the first evidence, to our knowledge, that immune responses can be induced safely against this class of self-antigens and pave the way for investigation of them as HIV- or tumor-associated targets."
01/01/2011 - "Preclinical animal studies convincingly demonstrate that tumor immunity to self-antigens can be actively induced and can translate into effective anti-tumor responses. "
01/01/2006 - "Although this is clearly beneficial in fighting off harmful infections and cancerous cells, the system must be carefully controlled to ensure that normal self-antigens are not targeted. "
01/01/2013 - "Effective clearance of an infection requires that the immune system rapidly detects and neutralizes invading parasites while strictly avoiding self-antigens that would result in autoimmunity. "
08/01/2005 - "Advances in our understanding of the roles of retroviral infection and autoimmune responses of T and B cells to PBC-specific autoantigens provides rationales for studies of the safety and efficacy of antiretroviral, immunosuppressive, and immunomodulatory agents in PBC. "
12/01/2015 - "Whereas HLA-E expression usually occurs at low levels, it is widely distributed amongst human tissues, has the ability to bind self and non-self antigens and to interact with NK cells and T lymphocytes, being important for immunosurveillance and also for fighting against infections. "
12/01/2015 - "The infection of certain pathogens, such as Helicobacter pylori, Chlamydophila psittaci, Borrelia burgdorferi, hepatitis C virus, or certain autoantigens cause these sites to generate a germinal center called the "acquired lymphoid tissue". "
10/28/2011 - "Prompt and efficient clearance of apoptotic cells is necessary to prevent secondary necrosis of dying cells and to avoid immune responses to autoantigens. "
10/01/2014 - "Moreover, apoptotic cells that cannot be cleared by phagocytes may undergo secondary necrosis and release proinflammatory compounds and potential autoantigens, which may contribute to the inflammatory micromilieu that leads to formation of skin lesions in the disease. "
04/01/2010 - "If dying cells are not promptly cleared, they undergo secondary necrosis and release nuclear autoantigens. "
11/01/2001 - "Secondary necrosis may occur in vivo in autoimmune disorders associated with impaired clearance of apoptotic cells and serve as a source of modified forms of specific autoantigens that might stimulate autoantibody responses under proinflammatory conditions."
11/01/2001 - "In light of the increasing interest in the immunologic consequences of defective clearance of apoptotic cells, we sought to determine whether autoantigens cleaved during apoptosis undergo an additional wave of proteolysis as apoptosis progresses to secondary necrosis in the absence of phagocytosis. "
|5.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/01/2011 - "Defective clearance of apoptotic cells has been shown in systemic lupus erythematosus (SLE) and is postulated to enhance autoimmune responses by increasing access to intracellular autoantigens. "
11/01/2002 - "Recent studies have indicated that cells undergoing apoptosis are the source of autoantigens which drive autoimmune responses in systemic lupus erythematosus (SLE). "
01/01/2015 - "Extensive work on experimental animal models clearly demonstrates that infectious agents can break immunological tolerance to self-antigens and induce autoimmune disorders, mainly systemic lupus erythematosus (SLE). "
12/01/2013 - "In systemic lupus erythematosus (SLE), the impairment in apoptosis can facilitate the initiation and maintenance of autoimmune responses to self antigens. "
06/01/2013 - "The mechanisms involved in breaking immunologic tolerance against nuclear autoantigens in systemic lupus erythematosus (SLE) are not fully understood. "
|5.||DNA (Deoxyribonucleic Acid)
|9.||Antigen-Antibody Complex (Immune Complex)
|10.||HLA-DR Antigens (HLA-DR)
|3.||Homologous Transplantation (Allograft)
|4.||Transplantation (Transplant Recipients)